Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer

Table 1

The comparison of surface receptors on NK cells in 30 healthy donors and 30 GC patients.

Surface receptors	Healthy donors (%)	GC patients (%)
CD56^high	2.70 ± 0.46	3.53 ± 0.44	0.195
CD16	90.97 ± 0.91	88.89 ± 1.09	0.149
NKp30	53.83 ± 4.26	35.71 ± 4.14	0.003
NKp46	36.45 ± 2.85	28.88 ± 2.45	0.048
NKG2D	96.21 ± 0.63	90.69 ± 1.56	0.002
DNAM-1	95.02 ± 0.61	90.57 ± 1.32	0.021
CD94	55.64 ± 3.52	57.94 ± 2.96	0.618
NKG2A	10.57 ± 2.49	13.27 ± 2.30	0.429
2B4	98.23 ± 0.68	97.93 ± 0.39	0.703
CD158a/h	21.98 ± 2.99	19.64 ± 2.55	0.553
CD158b	54.72 ± 2.94	47.83 ± 4.28	0.101
CD158e1	17.01 ± 2.42	18.73 ± 2.41	0.615